These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Oesophagectomy remains the gold standard for treatment of high-grade dysplasia in Barrett's oesophagus. Sujendran V; Sica G; Warren B; Maynard N Eur J Cardiothorac Surg; 2005 Nov; 28(5):763-6. PubMed ID: 16188449 [TBL] [Abstract][Full Text] [Related]
9. Endoscopic treatment of high-grade dysplasia and early cancer in Barrett's oesophagus. Conio M; Cameron AJ; Chak A; Blanchi S; Filiberti R Lancet Oncol; 2005 May; 6(5):311-21. PubMed ID: 15863379 [TBL] [Abstract][Full Text] [Related]
10. High-grade dysplasia and intramucosal adenocarcinoma in Barrett's esophagus: the role of esophagectomy in the era of endoscopic eradication therapy. Luna RA; Gilbert E; Hunter JG Curr Opin Gastroenterol; 2012 Jul; 28(4):362-9. PubMed ID: 22517568 [TBL] [Abstract][Full Text] [Related]
11. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus. Larghi A; Lightdale CJ; Memeo L; Bhagat G; Okpara N; Rotterdam H Gastrointest Endosc; 2005 Jul; 62(1):16-23. PubMed ID: 15990814 [TBL] [Abstract][Full Text] [Related]
12. Barrett's oesophagus: the new endoscopic modalities have a future. Deviere J Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i33-7. PubMed ID: 15711006 [TBL] [Abstract][Full Text] [Related]
13. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience. Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526 [TBL] [Abstract][Full Text] [Related]
14. Endoscopic therapy for Barrett's oesophagus. Blevins CH; Iyer PG Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):167-77. PubMed ID: 25743464 [TBL] [Abstract][Full Text] [Related]
15. KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus. Gossner L; May A; Stolte M; Seitz G; Hahn EG; Ell C Gastrointest Endosc; 1999 Jan; 49(1):8-12. PubMed ID: 9869716 [TBL] [Abstract][Full Text] [Related]
16. Occult adenocarcinoma after esophagectomy for Barrett's high-grade dysplasia. Donnellan F; Harewood GC; Patchett SE Gastrointest Endosc; 2010 Feb; 71(2):429. PubMed ID: 20152322 [No Abstract] [Full Text] [Related]
17. Endotherapy for Barrett's esophagus with high-grade dysplasia and intramucosal carcinoma. Schembre DB J Gastrointest Surg; 2009 Jul; 13(7):1172-8. PubMed ID: 19322616 [No Abstract] [Full Text] [Related]
18. Treatment of Barrett's esophagus with high-grade dysplasia. McAllaster JD; Buckles D; Al-Kasspooles M Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509 [TBL] [Abstract][Full Text] [Related]
19. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Pech O; Behrens A; May A; Nachbar L; Gossner L; Rabenstein T; Manner H; Guenter E; Huijsmans J; Vieth M; Stolte M; Ell C Gut; 2008 Sep; 57(9):1200-6. PubMed ID: 18460553 [TBL] [Abstract][Full Text] [Related]
20. Endoscopic management of dysplasia and early oesophageal cancer. Zeki SS; Bergman JJ; Dunn JM Best Pract Res Clin Gastroenterol; 2018; 36-37():27-36. PubMed ID: 30551853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]